The Combined Deficiency of Immunoproteasome Subunits Affects Both the Magnitude and Quality of Pathogen- and Genetic Vaccination-Induced CD8+ T Cell Responses to the Human Protozoan Parasite Trypanosoma cruzi by Ersching, Jonatan et al.
University of Massachusetts Medical School 
eScholarship@UMMS 
Open Access Articles Open Access Publications by UMMS Authors 
2016-04-29 
The Combined Deficiency of Immunoproteasome Subunits 
Affects Both the Magnitude and Quality of Pathogen- and Genetic 
Vaccination-Induced CD8+ T Cell Responses to the Human 
Protozoan Parasite Trypanosoma cruzi 
Jonatan Ersching 
Universidade Federal de Sao Paulo 
Et al. 
Let us know how access to this document benefits you. 
Follow this and additional works at: https://escholarship.umassmed.edu/oapubs 
 Part of the Immunity Commons, Immunopathology Commons, Immunoprophylaxis and Therapy 
Commons, and the Parasitic Diseases Commons 
Repository Citation 
Ersching J, Vasconcelos JR, Ferreira CP, Caetano BC, Machado AV, Bruna-Romero O, Baron MA, Ferreira 
LR, Cunha-Neto E, Rock KL, Gazzinelli RT, Rodrigues MM. (2016). The Combined Deficiency of 
Immunoproteasome Subunits Affects Both the Magnitude and Quality of Pathogen- and Genetic 
Vaccination-Induced CD8+ T Cell Responses to the Human Protozoan Parasite Trypanosoma cruzi. Open 
Access Articles. https://doi.org/10.1371/journal.ppat.1005593. Retrieved from 
https://escholarship.umassmed.edu/oapubs/2875 
Creative Commons License 
This work is licensed under a Creative Commons Attribution 4.0 License. 
This material is brought to you by eScholarship@UMMS. It has been accepted for inclusion in Open Access Articles 
by an authorized administrator of eScholarship@UMMS. For more information, please contact 
Lisa.Palmer@umassmed.edu. 
RESEARCH ARTICLE
The Combined Deficiency of
Immunoproteasome Subunits Affects Both
the Magnitude and Quality of Pathogen- and
Genetic Vaccination-Induced CD8+ T Cell
Responses to the Human Protozoan Parasite
Trypanosoma cruzi
Jonatan Ersching1¤, José R. Vasconcelos1,2, Camila P. Ferreira1, Braulia C. Caetano3,
Alexandre V. Machado4, Oscar Bruna–Romero5, Monique A. Baron6, Ludmila R.
P. Ferreira6,7, Edécio Cunha-Neto6, Kenneth L. Rock3, Ricardo T. Gazzinelli3,4,8☯*,
Maurício M. Rodrigues1☯†
1 Centro de Terapia Celular e Molecular and Departamento de Microbiologia, Imunologia e Parasitologia,
Universidade Federal de São Paulo - Escola Paulista de Medicina, São Paulo, São Paulo, Brazil,
2 Departamento de Biociências, Universidade Federal de São Paulo, Santos, São Paulo, Brazil,
3 Departments of Medicine and Pathology, University of Massachusetts Medical School, Worcester,
Massachusetts, United States of America, 4 Centro de Pesquisas René Rachou, FIOCRUZ, Belo Horizonte,
Minas Gerais, Brazil, 5 Departamento de Microbiologia, Imunologia e Parasitologia, Universidade Federal de
Santa Catarina, Florianópolis, Santa Catarina, Brazil, 6 Instituto do Coração (InCor), Faculdade de Medicina
- Universidade de São Paulo, São Paulo, São Paulo, Brazil, 7 Universidade Santo Amaro, São Paulo, São
Paulo, Brazil, 8 Departamento de Bioquímica e Imunologia, Instituto de Ciências Biológicas, Universidade
Federal de Minas Gerais, Belo Horizonte, Minas Gerais, Brazil
†Deceased.
☯ These authors contributed equally to this work.
¤ Current address: Whitehead Institute for Biomedical Research, Cambridge, Massachusetts, United States
of America
*Ricardo.Gazzinelli@umassmed.edu
Abstract
The β1i, β2i and β5i immunoproteasome subunits have an important role in defining the rep-
ertoire of MHC class I-restricted epitopes. However, the impact of combined deficiency of
the three immunoproteasome subunits in the development of protective immunity to intra-
cellular pathogens has not been investigated. Here, we demonstrate that immunoprotea-
somes play a key role in host resistance and genetic vaccination-induced protection against
the human pathogen Trypanosoma cruzi (the causative agent of Chagas disease), immunity
to which is dependent on CD8+ T cells and IFN-γ (the classical immunoproteasome
inducer). We observed that infection with T. cruzi triggers the transcription of immunoprotea-
some genes, both in mice and humans. Importantly, genetically vaccinated or T. cruzi-
infected β1i, β2i and β5i triple knockout (TKO) mice presented significantly lower frequen-
cies and numbers of splenic CD8+ effector T cells (CD8+CD44highCD62Llow) specific for the
previously characterized immunodominant (VNHRFTLV) H-2Kb-restricted T. cruzi epitope.
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Not only the quantity, but also the quality of parasite-specific CD8+ T cell responses was
altered in TKOmice. Hence, the frequency of double-positive (IFN-γ+/TNF+) or single-posi-
tive (IFN-γ+) cells specific for the H-2Kb-restricted immunodominant as well as subdominant
T. cruzi epitopes were higher in WT mice, whereas TNF single-positive cells prevailed
among CD8+ T cells from TKOmice. Contrasting with their WT counterparts, TKO animals
were also lethally susceptible to T. cruzi challenge, even after an otherwise protective vacci-
nation with DNA and adenoviral vectors. We conclude that the immunoproteasome subunits
are key determinants in host resistance to T. cruzi infection by influencing both the magni-
tude and quality of CD8+ T cell responses.
Author Summary
CD8+ t lymphocytes are cells of the immune system that mediate control of intracellular
infections by viruses, prokaryote as well as eukaryote pathogens. To confer protection,
these lymphocytes need to be elicited by pathogen peptides that are presented in associa-
tion with MHC class I molecules. The degradation of self and microbial proteins by cata-
lytic domains of the cytosolic proteasome β1, β2 and β5 subunits is intimately linked to the
generation of MHC class I-restricted epitopes, which in turn are important determinants
of the kinetics, specificity and efficiency of CD8+ T cell-mediated immunity. Importantly,
inflammatory stimuli trigger the expression of the inducible alternative β1i, β2i and β5i
subunits that form the immunoproteasomes. The qualitative and quantitative importance
of immunoproteasomes in generating CD8+ T cell epitopes has recently been demon-
strated in mice that are simultaneously devoid of the β1i, β2i and β5i subunits. In this
study, we explored the role of immunoproteasomes in host resistance to Trypanosoma
cruzi, a protozoan parasite that causes Chagas disease. We found that β1i, β2i and β5i tri-
ply deficient mice have an impaired response of CD8+ T cells and are highly susceptible to
primary infection with T. cruzi. We also demonstrated that host resistance induced by a
genetic vaccine able to protect normal mice from T. cruzi challenge fails to do so in the
immunoproteasome-deficient mice. Our study provides strong evidences that β1i, β2i and
β5i immunoproteasome subunits are important determinants of both the magnitude and
quality of CD8+ T cell responses as well as immune-mediated host resistance to a human
pathogen.
Introduction
CD8+ T cells are important mediators of pathogen control during intracellular infections. Suffi-
cient induction of these cells leads to pathogen elimination [1–8], whereas weak or exacerbated
CD8+ T cell stimulation may lead to pathology [9–17]. Therefore, the proper induction of
CD8+ T cells must be tightly regulated and may be co-opted in the development of new vac-
cines against intracellular pathogens [18–22].
Critical in the process of CD8+ T cell induction is the kinetics and efficiency of the provision
of MHC class I-restricted epitopes recognized by these lymphocytes, which is linked to the deg-
radation of mature proteins and defective ribosomal products in the cytosol by barrel-shaped
structures denoted proteasomes, as recently reviewed [23, 24]. The catalytic activity of protea-
somes is attributed to 3 subunits (β1 (Psmb6), β2 (Psmb7), and β5 (Psmb5)) located in each of
the two inner β rings of the 20S core. In addition, proteasomes featuring the alternative
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catalytic subunits β1i (LMP2 or Psmb9), β2i (MECL1 or Psmb10) and β5i (LMP7 or Psmb8)
are named immunoproteasomes, which are constitutively expressed in some hematopoietic
cells and may be induced by inflammatory stimuli such as IFN-γ, IFN-β or TNF in other cell
types (reviewed in [25]).
The immunoproteasomes enhance the quantity and diversity of MHC class I-restricted pep-
tides generated and their consequent impact on the magnitude and breath of protective
responses of CD8+ T cells against intracellular pathogens has long been studied by several
groups. However, the β1i, β2i and β5i proteins have a redundant role, and only partial pheno-
type is observed in mice lacking a single functional gene encoding one of the immunoprotea-
some subunits. Only recently a mouse concomitantly defective of all three immunoproteasome
genes (TKO mouse) was made available, allowing the observation that immunoproteasomes
are more relevant for the repertoire of MHC class I-presented peptides than thought before, so
much so that WT splenocytes are rejected by TKO mice [26]. However, the participation of
immunoproteasomes in the control of infections by most pathogens studied so far was only
incremental.
Here, we evaluated the role of immunoproteasomes in the CD8+ T cell-mediated immunity,
resistance to infection, and protective immunity conferred by genetic vaccination against Try-
panosoma cruzi, a human protozoan parasite and causative agent of Chagas disease. Because
control of infection by T. cruzi is critically dependent on CD8+ T cells and IFN-γ (reviewed in
[27]), we reasoned that the immunoproteasome could be specially relevant for protection in
this model. Confirming our hypothesis, we found that CD8+ T cell immune responses to T.
cruzi epitopes were remarkably weaker in TKOmice infected with T. cruzi or immunized with
an adenoviral vaccine vector expressing an immunodominant parasite antigen. Not only the
quantity, but also the quality of parasite-specific CD8+ T cell responses was altered in TKO
mice, as indicated by the higher frequency of double-positive (IFN-γ+/TNF+) or single-positive
(IFN-γ+) cells specific for immunodominant as well as subdominant T. cruzi epitopes in WT
versus TKO mice. Finally, another highly relevant finding was that both naïve and vaccinated
TKOmice were extremely susceptible to experimental infection, with most animals succumb-
ing to an otherwise non-lethal challenge. These observations establish that immunoprotea-
somes play a critical role in the generation of immunogenic peptides and the development of
protective T. cruzi-specific CD8+ T lymphocytes.
Results
Reduced antigen presentation of MHC class I-restricted T. cruzi epitopes
by immunoproteasome-deficient dendritic cells in vitro
Because dendritic cells constitutively express immunoproteasomes, we examined whether in
vitro-generated bone marrow-derived dendritic cells (BMDC) from TKOmice differed from
WT BMDC in antigen presentation capacity upon exposure to T. cruzi trypomastigotes or par-
ticles of the adenoviral vaccine vector expressing the immunodominant T. cruzi antigen ASP-2
(AdASP-2) [28]. Upon stimulation with parasites or adenovirus, we observed that WT and
TKO BMDCs upregulated the costimulatory marker CD86 equally well in vitro, whereas the
expression of H-2Kb molecules by TKO BMDC was lower than by their WT counterparts (Fig
1a and 1b). In addition, IL-12 p70 concentrations in the culture supernatants were similar
between WT BMDC and TKO BMDC (Fig 1c).
BMDC were then co-cultured with purified CD4+ or CD8+ T cells collected from T. cruzi-
infected mice. Previously, we have confirmed the cytosolic processing of H-2-restricted epitopes
from T. cruzi by incubating these purified T cells in vitro with T. cruzi- or AdASP-2-exposed
BMDC deficient in TAP-1 or treated with the proteasome inhibitor epoxomicin (S1 Fig).
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Consistent with the result showing lower MHC class I expression, TKO BMDC exposed to T.
cruzi or AdASP-2 stimulated significantly fewer IFN-γ-producing CD8+ T cells than WT
BMDC did, but no difference was observed when BMDC were incubated with synthetic
VNHRFTLV peptide corresponding to the immunodominant H-2Kb-restricted epitope from
ASP-2, or the ANYKFTLV and ANYDFTLV peptides that correspond to the respective sub-
dominant epitopes, thus indicating that the reduction in antigen presentation capacity from
TKO BMDC is due to the impaired processing of MHC class I-restricted epitopes (p<0.001, Fig
1d). Conversely, we observed that TKO andWT BMDC exposed to T. cruzi or AdASP-2 were
equally able to present MHC class II-restricted epitopes in vitro, as measured by their capacity
to stimulate similar numbers of IFN-γ-producing CD4+ T cells (Fig 1e). When T. cruzi- or
AdASP-2-exposed BMDCwere co-cultured with CD4+ or CD8+ T cells isolated from naïve
mice, no IFN-γ secretion was detected.
These results thus suggested the contribution of immunoproteasomes for the processing of
MHC class I-restricted T. cruzi epitopes delivered by the parasite itself or by an adenoviral vac-
cine vector.
Fig 1. Reduced in vitro presentation of MHC class I epitopes from T. cruzi by immunoproteasome-
deficient BMDC. In vitro-generatedWT (red) or TKO (blue) BMDC were incubated for 24 h with
trypomastigotes of T. cruzi Y strain (m.o.i. = 3), the adenoviral vector AdASP-2 (m.o.i. = 50), or left untreated.
(a) Staining of H-2Kb and (b) CD86 gated in CD11c+ BMDC. (c) IL-12 concentration in culture supernatants
obtained after 24 h of cultivation as measured by ELISA. (d) Purified CD8+ or (e) CD4+ T cells were obtained
from the spleens of WTmice infected with T. cruzi 15 days earlier. The purified T cells were admixed with WT
or TKO BMDC and incubated overnight. Where indicated, BMDC were loaded with the peptides VNHRFTLV,
ANYKFTLV, or ANYDFLTV, corresponding to H-2Kb-restricted epitopes from T. cruzi. The frequency of IFN-
γ-producing cells was detected by ELISPOT. SFC: spot-forming cells. Results are shown as individual values
and as the mean ± SEM for each group (n = 3). One of two independent experiments is presented. Asterisks
indicate that the values observed in TKOmice were significantly lower than those in WTmice
(****P<0.0001).
doi:10.1371/journal.ppat.1005593.g001
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T. cruzi induces the transcription of immunoproteasome genes in mice
and humans
To further investigate the participation of immunoproteasomes in the response to T. cruzi
infection in vivo, we performed semi-quantitative real-time PCR with primers specific to β1,
β2, β5 and the respective surrogate β1i, β2i, and β5i genes using cDNA obtained from heart
samples of naïve and T. cruzi-infected mice 12 dpi. Additionally, the corresponding human
mRNAs were quantified in heart samples from healthy and chronic chagasic patients with car-
diomyopathy. These experiments demonstrated that in vivo infection with T. cruzi induces the
transcription of immunoproteasome genes in both mice and humans (Fig 2).
Impaired immunity of specific CD8+ T cells and higher tissue parasitism
upon T. cruzi infection of immunoproteasome-deficient mice
Following experimental infection, we evaluated the expression of MHCmolecules by splenic
antigen-presenting cells (CD11c+ I-Ab+ CD3- CD19-) from naïve animals and from mice chal-
lenged with T. cruzi twenty days earlier. As expected, T. cruzi infection induced the upregula-
tion of MHC class I in both WT and TKO cells (p<0.001 in both cases), suggesting the
participation of the conventional immunoproteasome catalytic subunits in the processing of
H-2Kb-restricted epitopes. Nevertheless, the expression of H-2Kb molecules on the surface of
TKO cells from naïve or infected mice was significantly lower than on their counterpart WT
cells (p<0.01, Fig 3a), indicating the contribution of immunoproteasomes to the processing of
T. cruzi epitopes. In contrast, the expression of I-Ab molecules on the surface of TKO antigen-
presenting cells from naïve or infected mice was similar to their WT counterparts (Fig 3b).
Accordingly, naïve and infected TKOmice presented lower numbers of total CD8+ T cells in
the spleen in comparison to WT animals, whereas no difference in total CD4+ T cell numbers
was observed between WT and TKO mice (Fig 3c and 3d). When results were expressed in cell
frequencies, these differences remained exclusive for the CD8+ T cell compartment (S2 Fig).
The immune response mediated by CD8+ T cells was evaluated in detail in WT and TKO
mice 20 days after infection with T. cruzi. The total numbers of splenic CD8effector cells (CD8
+-
CD44highCD62Llow) in infected TKOmice were significantly lower than the corresponding
numbers in infected WT animals (p<0.01, Fig 4b). Using pentamer staining, we also measured
the numbers of CD8+ T cells specific for the previously characterized immunodominant, H-
2Kb-restricted, T. cruzi epitope VNHRFTLV [29, 30]. Again, these numbers were considerably
lower in TKOmice than those observed in infected WT mice (p<0.01, Fig 4c and 4d). We fur-
ther evaluated the function of CD8+ T cells through their pattern of IFN-γ/TNF production as
assessed by ex vivo restimulation of splenocytes with the peptides VNHRFTLV, ANYKFTLV,
and ANYDFTLV (corresponding to T. cruziH-2Kb-restricted epitopes) followed by intracellu-
lar staining. In presence of the two former peptides, higher numbers of CD8+ T cells from
infected WTmice produced IFN-γ and/or TNF in comparison to the infected TKO animals,
whereas naïvemice did not respond regardless of their background (p<0.0001, Fig 4e and 4f).
We also stimulated splenocytes with the peptides VNYDFTLV and ANYNFTLV, which have
similar sequences to the described H-2Kb-restricted epitopes from T. cruzi, in order to test
whether they became immunogenic in TKO animals. However, no cytokine response was
observed (Fig 4f). These results were similar when expressed in cell frequencies and were fur-
ther confirmed by estimating the numbers of IFN-γ-producing CD8+ T cells by ELISPOT
assay after incubation with each peptide (S3 Fig). The specific response to the subdominant
epitope ANYDFTLV elicited by T. cruzi infection was higher in WT mice compared with TKO
mice; however, statistical significance was reached only in the ELISPOT assay (S3 Fig). Not
only the quantity, but also the quality of specific CD8+ T cell cytokine response was altered in
Role of Immunoproteasome in Immunity to T. cruzi
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Fig 2. T. cruzi induces the transcription of immunoproteasome genes in mice and humans.Relative
quantification (RQ) of the indicated mRNA levels was measured by real-time PCR in myocardial tissue
samples from (a) WTmice infected with T. cruzi (Y strain) 12 dpi or from (b) chronic chagasic patients with
cardiomyopathy as compared to samples obtained from naïvemice or healthy subjects, respectively. Results
are shown as individual values and as the mean ± SEM for each group. For mouse groups, n = 5, pooled from
two independent experiments, and for human samples, n = 14. Asterisks indicate that the values observed for
immunoproteasome genes were significantly higher than those for conventional proteasome genes (*P<0.05
***P<0.001 ****P<0.0001).
doi:10.1371/journal.ppat.1005593.g002
Fig 3. Mice lacking immunoproteasomes have diminished expression of MHC class I molecules and
reduced numbers of CD8+ T cells.WT and TKOmice were infected s.c. with 104 T. cruzi parasites (Y strain)
or left uninfected. Twenty days later, spleen cells were collected and stained for surface markers. (a) gMFI
(geometric mean of fluorescence intensity) of H-2Kb and (b) I-Ab stainings are shown after gating in CD11c+
I-Ab+ CD3- CD19- cells. Total numbers of CD8+ and CD4+ T cells in the spleen of these animals are shown in
(c) and (d), respectively. Results are shown as individual values and as the mean ± SEM for each group
(n = 3). One representative of at least two independent experiments is shown. Asterisks indicate that the
values observed for TKOmice were significantly different than those for WTmice (*P<0.05 **P<0.01
***P<0.001).
doi:10.1371/journal.ppat.1005593.g003
Role of Immunoproteasome in Immunity to T. cruzi
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Fig 4. Immunoproteasome-deficient mice present impaired immunity of specific CD8+ T cells upon
infection with T. cruzi. (a) Experiment design: WT and TKOmice were infected s.c. with 104 T. cruzi
parasites (Y strain) or left uninfected. Twenty days later, the response of CD8+ T cells was assessed in the
spleen. (b) Total numbers of CD8+ CD44high CD62Llow cells. (c) Representative samples and (d) total
numbers of specific CD8+ T cells stained with H-2Kb-VNHRFTLV pentamers. (e) Representative samples
and (f) numbers of CD8+ splenic cells positively stained with anti-TNF and/or anti-IFN-γ after ex vivo
restimulation with the indicated peptides corresponding to known or hypothetical T. cruziMHC class I-
restricted epitopes. (g) Combination of cytokines stained in responder CD8+ T cells from spleens of T. cruzi-
infected mice restimulated ex vivowith VNHRFTLV peptide. Results are shown as individual values and as
the mean ± SEM for each group (n = 3). One representative of two independent experiments is shown.
Asterisks indicate that the values observed for TKOmice were significantly lower than those for WTmice
(**P<0.01 ****P<0.0001).
doi:10.1371/journal.ppat.1005593.g004
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TKO animals. Among the cells that produced any cytokine, the frequencies of double-positive
(IFN-γ+/TNF+) or single-positive (IFN-γ+) cells after restimulation with VNHRFTLV peptide
were higher in infected WT mice compared with cells from infected TKOmice (p<0.01, Fig
4g), whereas TNF single-positive cells prevailed among CD8+ T cells from TKOmice (Fig 4g).
We also compared the frequencies of splenic CD4effector (CD4
+CD44highCD62Llow) cells in
mice infected 20 days earlier, and we also observed that upon infection, CD4+ T cells express-
ing IFN-γ and/or TNF can be detected without ex vivo restimulation, as previously reported
[31]. No difference was observed in the effector phenotype or function of CD4+ T cells between
WT and TKOmice infected with T. cruzi (S4 Fig).
Based on the experiments above, we concluded that following infection with T. cruzi, the
generation of specific CD8+ T cells was severely impaired and profile of cytokine production
altered in TKO mice.
To test whether the impaired immunity of CD8+ T cells in TKOmice correlates with
reduced resistance to infection with T. cruzi, we further estimated the amount of parasite DNA
in infected WT and TKO mice. As shown in Fig 5, in the heart and spleen, the quantity of T.
cruzi DNA was significantly higher in TKOmice as compared with WT animals (p<0.0001).
Failure of genetic vaccination in mice devoid of immunoproteasomes
Given that CD8+ T cells are critical for immunity against T. cruzi infection, we developed an
immunization regimen that successfully vaccinates highly susceptible mice against systemic
lethal infection [32–34]. For that purpose, we used recombinant plasmid DNA for priming and
human replication-defective recombinant adenovirus type 5 for boost, both vectors expressing
ASP-2 of T. cruzi. This vaccination protocol elicited a long-lived protective immune response
mediated by CD8+ effector and effector memory T cells [35, 36].
When we compared the response of CD8+ T cells, we found significantly lower numbers of
CD8effector cells in ASP-2-vaccinated TKO mice than in ASP-2-vaccinated WT animals
(p<0.05, Fig 6b). As in the case of T. cruzi-infected mice, the numbers of cells specific for the
VNHRFTLV epitope among the splenic CD8+ T cells of ASP-2-vaccinated TKO mice were sig-
nificantly lower than those observed in ASP-2-vaccinated WTmice (p<0.0001, Fig 6c and 6d).
In addition, the numbers of specific CD8+ T cells producing IFN-γ and/or TNF upon ex vivo
restimulation with the peptide VNHRFTLV were also lower in the population of splenic CD8+
T cells from ASP-2-vaccinated TKO mice compared with cells from ASP-2-vaccinated WT
mice (p<0.0001, Fig 6e and 6f). The quality of the immune response of the CD8+ T cells from
ASP-2-vaccinated WTmice in comparison to TKO animals was not as different as observed in
T. cruzi-infected mice, and IFN-γ single-positive or IFN-γ/TNF double-positive cells predomi-
nated in both WT and TKO animals (Fig 6g). When expressed in cell frequencies, or when the
cytokine response was assessed by ELISPOT, similar differences between WT and TKOmice
were found (S5 Fig). Moreover, the response of CD4+ T cells to genetic vaccination with Asp-2
was similar between WT and TKO animals, as measured by in vivo incorporation of BrdU in
CD44high cells or intracelllular staining of IFN-γ after ex-vivo restimulation with AdASP-
2-infected cells (S6 Fig). Overall, we concluded that following genetic immunization or infec-
tion with T. cruzi, TKO mice were severely impaired in the generation of CD8+ T cell-mediated
immune responses to the VNHRFTLV epitope.
The ultimate aim of our study was to determine whether immunoproteasomes are impor-
tant for resistance against infection with T. cruzi. Because MHC I-restricted CD8+ T cells have
been described as important for protective immunity in both naïve and vaccinated mice, as
estimated based on parasitemia and mouse survival, we expected that TKOmice would be
more susceptible to infection than their WT counterparts. Accordingly, we observed that after
Role of Immunoproteasome in Immunity to T. cruzi
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challenge, TKO mice vaccinated with the βgal unrelated control or with ASP-2 presented levels
of parasitemia that were about one order of magnitude higher than those in WT mice vacci-
nated with the βgal control (p<0.01, Fig 7a). Notably, the parasitemia detected in TKOmice
previously immunized with ASP-2 was indistinguishable from that observed among TKOmice
that had received the unrelated βgal-expressing vector. In contrast, and as previously described
[32], the parasitemia observed after challenge of ASP-2-vaccinated WTmice was significantly
lower than that measured among βgal-vaccinated control animals (p<0.01, Fig 7a). Not only
did TKOmice have higher parasitemia, but most of them also succumbed to an otherwise non-
lethal infection. A total of 87.5% of TKOmice vaccinated with the βgal control succumbed
before 45 days after infection. ASP-2-vaccinated TKO mice survived slightly longer, but still,
85.7% of the mice died before day 50 after challenge (Fig 7b). The increase in survival was sta-
tistically significant in the groups of WT mice compared with TKO mice (p<0.001). These
results support the association between the decrease in the frequency of specific splenic CD8+
T cells and the limited parasite control in TKOmice.
Because different strains of T. cruzimay present distinct patterns of infectivity in mice, we
also tested whether TKOmice were more susceptible to infection with parasites of the CL
strain. Similar to the case of mice infected with parasites of the Y strain, we observed that TKO
mice were highly susceptible to infection and unable to control their parasitemia, succumbing
before 25 days following infection with an otherwise non-lethal challenge (S7 Fig).
An altered CD8+ T cell repertoire has been previously described in TKO mice in compari-
son to WT animals [26]. This was explained by a different repertoire of immunogenic peptides
presented by thymic epithelial cells from TKO mice. To test whether a difference in the T cell
repertoire accounted for most of the defective immune response observed in TKO mice, we
generated bone marrow chimeras. Irradiated WTmice were reconstituted with bone marrow
from either WT (WT-WT) or TKO (TKO-WT) animals and after 8 weeks these mice were
infected with T. cruzi. After 20 days of infection, the response of CD8+ T cells was assessed (Fig
8a). In this set up, bone marrow-derived antigen presenting cells lack immunoproteasomes in
TKO-WT chimeras, as indicated by the lower expression of H-2Kb molecules on CD11c+
splenic cells from these animals in comparison to WT-WT mice (Fig 8b). Conversely, epithelial
thymic stromal cells are WT in both WT-WT and TKO-WT chimeras, thus allowing similar
selection of CD8+ T cells. Similar CD8+ T cell repertoire between WT-WT and TKO-WT chi-
meras was inferred by the indistinguishable staining of CD8+ T cells with TCR Vβ antibodies
panel (Fig 8c). Upon T. cruzi infection, the chimeric TKO-WT animals presented lower
Fig 5. Mice devoid of immunoproteasomes present higher tissue parasitism upon infection with T.
cruzi.WT and TKOmice were infected s.c. with 104 T. cruzi parasites (Y strain) or left uninfected. Twenty
days later, their (a) hearts and (b) spleens were collected, and the number of parasites/50 ng genomic DNA
was measured by real-time PCR. Results are shown as individual values and as the mean ± SEM for each
group (n = 3). One representative of two independent experiments is shown. Asterisks indicate that the
values observed for TKOmice were significantly higher than those for WTmice (****P<0.0001).
doi:10.1371/journal.ppat.1005593.g005
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Fig 6. Immunoproteasome-deficient mice present impaired immunity of specific CD8+ T cells upon
genetic vaccination against T. cruzi. (a) Experiment design: WT and TKOmice were primed with empty
plasmid DNA (pcDNA3) or a vector expressing ASP-2 (pIgCl9) and boosted after 21 days with adenovirus 5
expressing beta-galactosidase (Adβ-gal) or ASP-2 (AdASP-2), respectively. Fifteen days later, the response
of CD8+ T cells was assessed in the spleen. (b) Total numbers of CD8+ CD44high CD62Llow cells. (c)
Representative samples and (d) total numbers of specific CD8+ T cells stained with H-2Kb-VNHRFTLV
pentamers. (e) Representative samples and (f) numbers of CD8+ splenic cells positively stained for TNF and/
or IFN-γ after ex vivo restimulation with the peptide VNHRFTLV corresponding to the immunodominant T.
cruziMHC class I-restricted epitope from ASP-2. (g) Combination of cytokines stained in responder CD8+ T
cells from spleens of ASP-2-vaccinated mice restimulated ex vivo with VNHRFTLV peptide. Results are
shown as individual values and as the mean ± SEM for each group (n = 4). One representative of two
independent experiments is shown. Asterisks indicate that the values observed for TKOmice were
significantly lower than those for WTmice (*P<0.05 ****P<0.0001).
doi:10.1371/journal.ppat.1005593.g006
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numbers of VNHRFTLV-specific CD8+ T cells stained with pentamers (p<0.05, Fig 8d and 8e)
and lower numbers of cytokine-producing CD8+ T cells specific to VNHRFTLV and
ANYKFTLV epitopes (p<0.001, Fig 8f and 8g), although the response to the subdominant epi-
tope ANYDFTLV was comparable between WT-WT and TKO-WT chimeras (Fig 8f and 8g).
Once again, the frequency of double-positive (IFN-γ+/TNF+) or single-positive (IFN-γ+) CD8+
T cells after restimulation with VNHRFTLV peptide was higher in infected WT-WT chimeric
mice compared with cells from infected TKO-WTmice (p<0.01, Fig 8h).
Moreover, WT-WT and TKO-WT chimeras were vaccinated with AdASP-2 and the specific
CD8+ T cell response was evaluated after 20 days (Fig 9a). Again, splenic CD11c+ cells from
TKO-WTmice presented lower expression of H-2Kb (Fig 9b), whereas the staining of CD8+ T
cells with TCR Vβ antibodies panel was similar between TKO-WT and WT-WT animals (Fig
9c). Despite homogenous repertoire of CD8+ T cells, the number and cytokine effector function
of VNHRFTLV-specific CD8+ T cells was significantly reduced in AdASP-2-vaccinated
TKO-WTmice in comparison to AdASP-2-vaccinated WT-WT mice (Fig 9d–9h).
Because even WT-WT chimeric mice became highly susceptible to T. cruzi challenge, suc-
cumbing to infection from 22 days after challenge, comparisons between WT-WT and
TKO-WT animals in terms of resistance to infection and vaccine-induced protection were not
possible. Nonetheless, these experiments sustain the notion that the impaired immunity of
CD8+ T cells in T. cruzi-infected or genetically vaccinated animals lacking all immunoprotea-
some genes could not be solely attributed to an altered T cell repertoire.
Discussion
The recognition by CD8+ T lymphocytes of antigens displayed on the context of MHC class I
molecules is a fundamental requirement for the control of tumors and intracellular infections
by viruses, fungi, bacteria and parasites. Proteasomes are of paramount importance in the
Fig 7. Failure of genetic vaccination-induced protection against T. cruzi in mice lacking
immunoproteasomes.WT and TKOmice (n = 7–8) were primed with empty plasmid DNA (pcDNA3) or a
plasmid vector expressing ASP-2 (pIgCl9) and boosted after 21 days with adenovirus 5 expressing beta-
galactosidase (Adβ-gal) or ASP-2 (AdASP-2), respectively. Fifteen days later, the mice were challenged s.c.
with 104 T. cruzi parasites (Y strain). (a) Parasitemia and (b) Kaplan-Meier survival curves for each mouse
group are presented. Parasitemia is expressed as the mean ± SEM. The values of peak parasitemia (day 8)
were log transformed and compared by one-way ANOVA followed by Tukey’s HSD test, which showed that i)
ASP-2-immunizedWTmice displayed levels of parasitemia significantly lower than those of the other mouse
groups (p<0.01 in all cases), ii) the parasitemia values of TKOmice (vaccinated or control) were higher than
those of WTmice (p<0.01 in all cases), and iii) no difference between vaccinated and control mice was
detected among TKO animals. Comparison of the survival curves using the log-rank (Mantel-Cox) test
indicated that i) vaccinated and control WT mice survived significantly longer (p<0.001) than TKOmice did,
and ii) although vaccinated TKOmice survived slightly longer than control TKOmice did, no statistical
significance was reached. Data was pooled from three independent experiments (n = 7–8).
doi:10.1371/journal.ppat.1005593.g007
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processing of antigens in the MHC class I pathway. However, the specific contribution of alter-
native proteasome catalytic subunits β1i, β2i and β5i (as opposed to the canonical active sites)
to the generation of MHC class I-restricted epitope repertoire was thought to be, at most, incre-
mental until the recent development of a mouse model simultaneously devoid of β1i, β2i and
β5i subunits (TKO mice) [26]. In that study, major differences in the quantity and quality of
epitopes recognized by CD8+ T cells was reported, suggesting that models where only one or
two subunits are targeted might underestimate the relevance of immunoproteasomes in anti-
gen processing and presentation. Although it is reasonable to assume that immunoprotea-
some’s role in epitope abundance and specificity may lead to altered resistance to a pathogen,
supportive data to this assumption remain relatively scarce. Here we explored the TKOmouse
model to further investigate the role of immunoproteasomes in the development of protective
Fig 8. Impaired immunity of specific CD8+ T cells upon infection with T. cruzi of WTmice reconstituted with immunoproteasome-deficient bone
marrow. (a) Experiment design: WTmice were irradiated and reconstituted with WT (WT-WT) or TKO (TKO-WT) bone marrow. After 8 weeks, the chimeric
animals were infected s.c. with 104 T. cruzi parasites or left uninfected. Twenty days later, the response of CD8+ T cells was assessed in the spleen. (b) gMFI
(geometric mean of fluorescence intensity) of H-2Kb staining of CD11c+ splenic cells fromWT-WT and TKO-WT chimeras. (c) Staining of TCR Vβ chains
gated in CD8+ T cells from naïveWT-WT and TKO-WT chimeras. (d) Representative samples and (e) total numbers of specific CD8+ T cells stained with H-
2Kb-VNHRFTLV pentamers. (f) Representative samples and (g) total numbers of CD8+ splenic cells positively stained with anti-TNF and/or anti-IFN-γ after
ex vivo restimulation with the indicated peptides corresponding to known or hypothetical T. cruziMHC class I-restricted epitopes. (h) Combination of
cytokines stained in responder CD8+ T cells from spleens of T. cruzi-infected mice restimulated ex vivowith VNHRFTLV peptide. Results are shown as
individual values and as the mean ± SEM for each group (n = 3). One representative of two independent experiments is shown. Asterisks indicate that the
values observed for TKOmice were significantly lower than those for WTmice (*P<0.05 **P<0.01 ***P<0.001 ****P<0.0001).
doi:10.1371/journal.ppat.1005593.g008
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immunity to a pathogen. Trypanosoma cruzi, a neglected human parasite, was of didactical use
as a model, since protective immunity against it is highly dependent on CD8+ T cell function
and IFN-γ (the major inducer of immunoproteasomes). The TKO mice exhibited a drastically
reduced response of CD8+ T cells specific for immunodominant and subdominant epitopes
after T. cruzi infection, whereas the response of CD4+ T cells was unaltered. Surprisingly, natu-
ral resistance to infection in the absence of immunoproteasomes was seriously compromised
and even more unexpectedly the protection induced by genetic vaccination was completely
abolished, indicating that the immunoproteasome catalytic subunits, rather than the conven-
tional proteolytical sites, are essential for the processing of T. cruzi epitopes related to
Fig 9. Impaired immunity of specific CD8+ T cells upon genetic vaccination of WTmice reconstituted with immunoproteasome-deficient bone
marrow. (a) Experiment design: WTmice were irradiated and reconstituted with WT (WT-WT) or TKO (TKO-WT) bone marrow. After 8 weeks, chimeric mice
were vaccinated with adenovirus 5 expressing beta-galactosidase (Adβ-gal) or ASP-2 (AdASP-2). Twenty days later, the response of CD8+ T cells was
assessed in the spleen. (b) gMFI (geometric mean of fluorescence intensity) of H-2Kb staining of CD11c+ splenic cells fromWT-WT and TKO-WT chimeras.
(c) Staining of TCR Vβ chains gated in CD8+ T cells fromWT-WT and TKO-WT chimeras genetically immunized with Adβ-gal. (d) Representative samples
and (e) total numbers of specific CD8+ T cells stained with H-2Kb-VNHRFTLV pentamers. (f) Representative samples and (g) total numbers of CD8+ splenic
cells positively stained with anti-TNF and/or anti-IFN-γ after ex vivo restimulation with the peptide VNHRFTLV corresponding to the immunodominant MHC
class I-restricted epitope from ASP-2. (h) Combination of cytokines stained in responder CD8+ T cells from spleens of AdASP-2-vaccinated mice
restimulated ex vivowith VNHRFTLV peptide. Results are shown as individual values and as the mean ± SEM for each group (n = 3). One representative of
two independent experiments is shown. Asterisks indicate that the values observed for TKOmice were significantly lower than those for WTmice (**P<0.01
***P<0.001 ****P<0.0001).
doi:10.1371/journal.ppat.1005593.g009
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protective immunity generated during infection or vaccination. Our observations from chime-
ric mice are consistent with the hypothesis that the defect in TKOmice is the inability of anti-
gen presenting cells to process protective epitopes to CD8+ T cells, rather than the variation of
naïve CD8+ T cell repertoire. Also, we were unable to detect any shift in the immunodomi-
nance pattern of TKO mice relatively to WT counterparts.
We have previously reported that the induction of CD8+ T cell responses to T. cruzi is
remarkably delayed and suboptimal, with most cells expressing high levels of the proapoptotic
marker CD95 [16]. Conversely, genetic vaccination with adenoviral vectors induces a rapid,
expanded, polyfunctional and highly viable CD8+ T cell response that differentiates into a
long-lasting memory pool, as reported for T. cruzi as well as other pathogens [33–36]. Here, we
report that the function of T. cruzi-specific CD8+ T cell responses was altered in the absence of
immunoproteasomes, as indicated by the higher frequency of TNF single-positive cells in TKO
animals as opposed to a prevailing compartment of IFN-γ single-positive or IFN-γ and TNF
double-positive cells in immunoproteasome-sufficient mice. This difference, however, was
more pronounced during infection than upon genetic vaccination with Asp-2. It is acknowl-
edged that IFN-γ is of major importance for control of T. cruzi infection and its induction is
tightly regulated, whereas TNF, expressed throughout the course of infection, is of secondary
importance to parasite control [13, 27, 37]. Our results may suggest that in our model the
threshold of antigen presentation required to induce TNF production by CD8+ T cells might
be lower than the levels of stimulation necessary to induce IFN-γ. Consistently, the data pre-
sented here reinforce the notion that AdASP-2 is remarkably more potent than T. cruzi at
inducing CD8+ T cell responses, since even in the absence of immunoproteasomes the viral
vector was able to stimulate the production of IFN-γ-secreting cells. Therefore, even in the
absence of immunoproteasomes, the antigen pool generated by the adenoviral vaccine could be
cleaved by conventional proteasomes without severely compromising the induction of polyfun-
cional CD8+ T cells (yet lower number of cells are induced), in contrast to the observations
from experimental infection. In fact, we have previously observed that CD8+ T cells specific to
subdominant epitopes from T. cruzi can be induced by adenoviral vaccination, but not by pro-
tozoan infection, in line with the idea that the provision of epitopes is enhanced during genetic
vaccination [33].
Presumably, the lower expression of MHC class I in TKOmice is inextricably linked to a
defect in generating peptides that bind to H-2 molecules. We found that upon infection with T.
cruzi or adenovirus expressing ASP-2, dendritic cells from TKO background were highly
impaired at presenting antigen to WT CD8+ T lymphocytes explanted from either infected or
vaccinated mice. These results contrasted with the fact that WT and TKO BMDC loaded with
VNHRFTLV, ANYKFTLV, or ANYDFTLV peptides were equally able to stimulate T. cruzi-
specific CD8+ T cells in vitro. These results suggest that the defects in antigen presentation
capacity of TKO cells are due to the compromised processing of epitopes. These findings are
consistent with a previous study indicating that in absence of immunoproteasomes the presen-
tation of protein antigens that need to be cleaved is compromised, whereas no defect is
observed when the processed epitope is directly expressed by a minigene [26]. Nonetheless,
dendritic cells lacking immunoproteasomes still upregulate MHC class I molecules and present
epitopes recognized by CD8+ T cells upon infection with T. cruzi or genetic vaccination with
Asp-2, an effect most likely attributed to the processing of antigen by the canonical catalytic
subunits of the proteasome.
In addition to the poor antigen-presenting function of TKO cells, the immunodominance of
epitopes could have been shifted due to the absence of immunoproteasomes, as previously
described [38–40]. Although we only tested peptides representing 3 known epitopes and 2
other hypothetical ones, we could not find relevant changes in the immunodominance pattern.
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Independently of their specificities or hierarchies, the CD8+ T cells activated in TKOmice were
always reduced in comparison to WT counterparts.
An altered CD8+ T cell repertoire has been previously described in TKO mice in compari-
son to WT animals [26]. Hence, distinct naïve T cell repertoires could also explain the discrep-
ancies in CD8+ T cell response between TKO andWT mice [26, 41]. It is assumed that this
difference in the repertoire of CD8+ T cells fromWT and TKOmice is due to MHC I-mediated
presentation of a different repertoire of peptides by epithelial cells from thymus during T cell
development. To address this issue we performed experiments using chimeras, where recipient
WT mice received bone marrows from either WT or TKOmice. The results obtained from
these experiments suggest that it is unlikely that a difference in the T cell repertoire accounted
for most of the limited immune response observed in TKOmice. In the same direction, the
transfer into TKO mice of WT CD8+ T cells or of the P14 transgenic CD8+ T cell clone specific
to GP33 epitope was unable to restore the capacity of TKO animals to optimally respond to
LCMV infection [26].
Not only did TKOmice have diminished CD8+ T cell immune responses to parasite-derived
epitopes, but they were also no longer resistant to infection with T. cruzi. It is reasonable to
hypothesize that the susceptibility to infection and the weak CD8+ T cell-mediated immunity
are linked because in the mouse models that we used (naïve and vaccinated), CD8+ T cells have
been described as being critically involved in the control of parasitemia and in survival [30, 32].
Nevertheless, in addition to the low numbers of specific CD8+ T cells, other factor(s) may also
account for the extreme susceptibility that we observed. For instance, a second likely source of
reduced resistance may stem from the effector phase of the immune response. During T. cruzi
infection, large amounts of IFN-γ are produced and can be detected in the serum [42]. As
immunoproteasomes become the dominant form of proteasomes in IFN-γ-activated cells, their
absence may drastically reduce the antigen presentation capacity of target cells infected with T.
cruzi. This aspect may further contribute to the impaired efficacy of the few CD8+ T cells gen-
erated during the priming phase.
It is worth mentioning that the susceptibility of TKO mice occurred in parallel to undetect-
able changes in presentation of MHC II-restricted epitopes to CD4+ T cells and in the genera-
tion of CD4effector cells during infection. These findings are also in agreement with previous
observations that CD4+ T cell-mediated immune responses were similar in TKO and WTmice
in different infection models [26].
The susceptibility of TKO mice may also be linked to a larger inflammatory reaction and to
more severe myocardial tissue damage. Recently, immunoproteasomes have been described as
protecting the heart from excessive inflammatory tissue damage due to acute coxsackievirus B3
(CVB3)-induced myocarditis [43]. Because T. cruzimay infect myocardial cells, whether a sim-
ilar event is associated with susceptibility to infection should be further investigated. This topic
may not be as important in the model of infection used in most of our studies, considering that
infection with parasites of the Y strain targets the spleen as well as the heart tissues [44]. How-
ever, other T. cruzi strains, such as the CL or the Colombian strain, cause severe acute heart
muscle injury and deserve further investigation [45].
Previous studies using mice genetically deficient for a single immunoproteasome subunit
(LMP7) also described poor induction of CD8+ T cells, but not CD4+ T cells, specific for anti-
gens of Toxoplasma gondii. As in our system, these mice were susceptible to an otherwise non-
lethal infection [46]. These results further corroborate the interpretation that immunoprotea-
somes are critical for the generation of intracellular parasite epitopes used for CD8+ T cell acti-
vation. Additionally, in the absence of immunoproteasomes, mouse survival after infection
with T. cruzi or T. gondii is compromised, pointing to the immunoproteasomes as key media-
tors of resistance to intracellular parasite infections.
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In other words, these protozoan infection models were instrumental at evidencing a specific
role of immunoproteasomes for the generation of critical epitopes required for protective
immunity.
By employing adenoviral vectors, our group developed genetic vaccination strategies against
T. cruzi. The immunization regimens confer protection to wild-type mice of different strains,
including the C57BL/6, BALB/c and A/Sn [16, 28]. From these, the A/Sn mice are the most sus-
ceptible and succumb to infection in less than 30 days, even when challenged with as low as
150 parasites of T. cruzi Y strain. Conversely, A/Sn mice survive T. cruzi infection if immunized
with AdASP-2 even on the same day of challenge [16]. At least in our animal facility, the
C57BL/6 mouse lineage is more resistant to T. cruzi infection and survives challenge with high
doses (10,000) of blood forms of T. cruzi. Therefore, the C57BL/6 mouse serves as a model to
study different aspects of the CD8+ T cell response related to resistance. Here, we observed that
mice devoid of immunoproteasomes in a C57BL/6 background are highly susceptible to T.
cruzi challenge. Unexpectedly, vaccination of these mice with AdASP-2 does not have any
effect in protecting the mice upon challenge, whereas in normal C57BL/6 mice the parasitemia
is reduced in about one order of magnitude. These results thus indicate that the efficacy of our
vaccination regimen is extremely dependent on the expression of β1i, β2i and β5i subunits of
the immunoproteasome, rather than the conventional proteolytical sites. In accordance with
this finding, a recent clinical trial aimed at testing the efficacy of the RTS,S vaccine against
malaria identified the upregulation of immunoproteasome genes among protected individuals
after challenge [47]. Altogether, these results may point to the induction of immunoprotea-
some genes as pivotal targets to be considered in the design of successful vaccination strategies
aimed at inducing CD8+ T cells.
In conclusion, we report that immunoproteasomes, rather than canonical proteasomes,
have a potentially underestimated role in inducing protective immunity both in primary infec-
tion as well as genetic vaccination against a human pathogen.
Materials and Methods
Ethics statement
This study was carried out in strict accordance with the recommendations in the Guide for the
Care and Use of Laboratory Animals of the Brazilian National Council of Animal Experimen-
tation (http://www.cobea.org.br/). The protocol was approved by the Committee on the Ethics
of Animal Experiments of the Institutional Animal Care and Use Committee at the Federal
University of Sao Paulo (Id # CEP 0426/09). The protocol using human samples was approved
by the Institutional Review Board of the University of São Paulo School of Medicine (Protocol
number 739/2005) and written informed consent was obtained from the patients. In the case of
samples from heart donors, written informed consent was obtained from their families.
Patients
Myocardial left ventricular free wall heart samples were obtained from end-stage heart failure
chronic chagasic patients with cardiomyopathy (7 females, 7 males, 15–61 years old). Control
adult heart tissue from the left ventricular-free wall was obtained from nonfailing donor hearts
not used for cardiac transplantation due to size mismatch with available recipients (males, 17–
46 years old). Hearts were explanted at the time of heart transplantation at the Heart Institute
—InCor, University of São Paulo School of Medicine, São Paulo, SP, Brazil. For mRNA extrac-
tion, samples were quickly dissected, and myocardial tissue was frozen in liquid nitrogen and
stored at -80°C.
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Mice and parasites
Five- to 8-week-old female C57BL/6 mice were purchased from CEDEME (Federal University
of São Paulo). TKOmice were generated as described by Kincaid et al. [26] and were bred in
our own animal facility. Bloodstream trypomastigotes of the Y or CL strain of T. cruzi were
obtained from mice infected 7 or 15 days earlier. The concentration of parasites was estimated
and adjusted to 105 parasites/mL. Each mouse was inoculated with 104 trypomastigotes diluted
in 0.1 mL PBS administered subcutaneously (s.c.) at the base of the tail. Parasitemia was
assessed on the days indicated in each figure, which involved counting the number of parasites
per 5 μL blood.
Genetic vaccination
The plasmid pIgSP Cl.9 and AdASP-2 were generated, grown and purified as described previ-
ously [28, 32]. Control mice were immunized with pcDNA3 and human replication-deficient
adenovirus type 5 expressing βgal (Adβ-gal). The mice were inoculated intramuscularly (i.m.)
with 50 μg plasmid DNA into each tibialis anteriorismuscle. A total of 21 days later, these mice
received 50 μL of a viral suspension containing 2 X 108 plaque-forming units (pfu) of adenovi-
rus via the same locations. Immunological assays were performed on the days indicated in each
figure.
Peptides
Synthetic peptides VNHRFTLV, ANYKFTLV, and ANYDFTLV were purchased from Gen-
Script (Piscataway, NJ). The peptide purity was higher than 90%. Peptide identities were con-
firmed using a Q-Tof Micro equipped with an electrospray ionization source (Micromass,
UK). The pentamer H-2Kb-VNHRFTLV was purchased from ProImmune Inc. (Oxford, UK).
BMDC generation
Progenitor cells were flushed from femurs and cultured in vitro in RPMI 1640 supplemented
with 10 mMHEPES, 0.2% sodium bicarbonate, 59 mg/L penicillin, 133 mg/L streptomycin,
10% HyClone fetal bovine serum, 2 mM L-glutamine, 1 mM sodium pyruvate, 55 μM 2-mer-
captoethanol and 20 ng/mL GM-CSF (R&D Systems) at a concentration of 2 X 105 cells/mL.
After 4 days in culture, half of the medium volume was replaced with fresh medium. At day 6,
the resulting BMDCs were exposed to tissue-culture trypomastigotes of T. cruzi at a ratio of 3
parasites/cell or to AdASP-2 at a ratio of 50 pfu/cell for an additional 24 h. After 7 days in cul-
ture (and 24 h of T. cruzi or AdASP-2 exposure), the BMDCs were employed in in vitro antigen
presentation assays.
Immunological assays
The presence of IL-12p70 in the supernatant of the BMDCs was assessed after 7 days in culture
(and 24 h of T. cruzi or AdASP-2 exposure) using an ELISA (BD).
To perform the in vitro antigen presentation assays, spleen cells from naïve animals or mice
infected with T. cruzi 15 days earlier were harvested, and the CD8+ T cell population was iso-
lated through negative selection with a CD8+ T Cell Isolation Kit using MACS beads (Miltenyi)
according to the manufacturer’s specification, followed by staining with anti-CD8 PerCP (53–
6.7, BD) and sorting by FACS (BD FACSAria II). The CD8- fraction obtained after MACS iso-
lation was stained with CD4 PE Cy7 (GK1.5, BD) and also sorted by FACS. The isolated lym-
phocytes were co-cultured with BMDCs previously exposed to T. cruzi or AdASP-2 or left
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unexposed at a ratio of 1 BMDC to 5 CD8 or CD4 cells for 24 h, and the number of IFN-γ-
secreting cells was determined by ELISPOT, as described elsewhere [31].
For flow cytometry analyses, we used mouse splenocytes treated with ACK buffer (NH4Cl,
0.15 M; KHCO3, 10 mM; Na2-EDTA 0.1 mM; pH = 7.4) for lysing the erythrocytes. Single-cell
suspensions were washed in PBS, stained for 10 min at RT with biotinylated MHC I multimer
H-2Kb-VNHRFTLV, and stained for 20 min at 4°C with streptavidin-APC and CD8 FITC
(53–6.7). For the analyses of other cell-surface markers, single-cell suspensions from spleens of
mice were stained with CD11c APCCy7 (HL3), CD86 APC (GL1), CD11b PerCP (M1/70),
CD19 PE (ID3), CD3 PE (17A2), H-2Kb FITC (AF6-88.5), IAb biotinylated (25-9-17), strepta-
vidin PECy7, CD4 PeCy7 (RM4-5), CD8 Pacific Blue (53–6.7), CD62L APC (MEL-14), and
CD44 PE (IM7). Staining of TCR Vβ chains was performed using TCR Vβ Screening Panel Kit
(BD Pharmingen). Isotype control antibodies were PE-labeled hamster IgG1k and rat IgG1k,
and FITC-labeled IgG2ak. All antibodies and streptavidins were purchased from BD Pharmin-
gen. At least 500,000 cells were acquired on a BD FACS Canto II flow cytometer and analyzed
with FlowJo 8.7 (Tree Star, Ashland, OR).
For the intracellular staining (ICS) of cytokines (IFN-γ and TNF), splenocytes collected from
C57BL/6 or TKOmice were treated with ACK buffer. ICS was performed after in vitro culture
of splenocytes in the presence or absence of the peptides indicated in each figure. Cells were
washed 3 times in plain RPMI and re-suspended in cell culture medium consisting of RPMI
1640 medium supplemented with 10 mMHepes, 0.2% sodium bicarbonate, 59 mg/L of penicil-
lin, 133 mg/L of streptomycin, 10% Hyclone fetal bovine serum, 2 mM L-glutamine, 1 mM
sodium pyruvate, 55 μM 2-mercaptoethanol. The viability of the cells was evaluated using 0.2%
trypan blue exclusion dye to discriminate between live and dead cells. Cell concentration was
adjusted to 5 X 106 cells/mL in cell culture medium containing anti-CD28 (2 μg/mL), BDGolgi-
Plug (1 μL/mL) and monensin (5 μg/mL). In half of the cultures, a final concentration of 10μM
of the VNHRFTLV peptide was added. The cells were cultivated in V-bottom 96-well plates
(Corning) in a final volume of 200 μL in duplicate, at 37°C in a humid environment containing
5% CO2. After 8h incubation, cells were stained for surface markers with CD4 FITC (GK1.5)
and CD8 PerCP (53–6.7) on ice for 20 min. To detect IFN-γ and TNF by intracellular staining,
cells were then washed twice in buffer containing PBS, 0.5% BSA, and 2 mM EDTA, fixed and
permeabilized with BD perm/wash buffer. After being washed twice with BD perm/wash buffer,
cells were stained for intracellular markers using APC-labeled anti-IFN-γ (XMG1.2) and PE-
labeled anti-TNF (MP6-XT22) for 20 minutes on ice. Finally, cells were washed twice with BD
perm/wash buffer and fixed in 1% PBS-paraformaldehyde. At least 800,000 cells were acquired
on a BD FACS Canto II flow cytometer and then analyzed with FlowJo.
Real-time PCR
Total RNA was isolated from mice and human myocardial tissues with Trizol (Invitrogen), fol-
lowed by purification with Quick RNAMiniprep columns and DNAse I treatment (Zymo
Research). cDNA was synthesized with High Capacity cDNA Reverse Transcription Kit
(Applied Biosystems). To confirm the absence of genomic DNA control samples were used
without reverse transcriptase. RT-PCR was performed using Power SYBR PCRMastermix
(Thermo Scientific) and StepOne Plus thermo cycler (Applied Biosystems). mRNA levels were
normalized to HPRT (mouse) and beta-actin (human). Primer sequences are reported else-
where for murine (procedure B in [48]) and human [49] samples. Relative quantification was
calculated over naïve (mouse) or healthy (human) controls using Δ ΔCTmethod [50]. The pro-
tocol for quantification of T. cruzi DNA in heart and spleen samples was performed as
described elsewhere [51].
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Bone marrow chimeras
Eight-week-old female C57BL/6 mice were irradiated at 900 Rads. Each irradiated animal
received 10 × 10 6 bone marrow cells i.v. isolated from C57BL/6 or TKO female mice. Before
transfer, bone marrow cell suspensions were depleted of T cells with CD8a (Ly-2) MicroBeads
and CD4 (L3T4) MicroBeads (Miltenyi Biotec). Mice were given medicated water containing
sulfamethoxazole (200 mg/mL) and trimethroprim (40 mg/mL). Experiments were performed
8 weeks after bone marrow transfer.
Statistical analysis
Groups were compared using One Way ANOVA followed by Tukey’s HSD test (http://faculty.
vassar.edu/lowry/VassarStats.html). Parasitemia values were log transformed before compari-
son. The Log-rank (Mantel-Cox) test was used to compare mouse survival rates after challenge
with T. cruzi (http://bioinf.wehi.edu.au/software/russell/logrank/). The differences were con-
sidered significant when the P value was<0.05.
Supporting Information
S1 Fig. T. cruziMHC class I epitopes are processed through the cytosolic pathway. (a) TAP-
1-deficient mice had their phenotype confirmed by the absence of CD8+ T cells in the spleen.
(b) WT and TAP-1-deficient BMDC were incubated with LPS, T. cruzi or AdASP-2 and the
expression of MHC and co-stimulatory molecules on CD11c+ cells was assessed by flow cytom-
etry. These BMDC were co-cultured with (c) CD8+ or (d) CD4+ T cells isolated from the spleen
of T. cruzi-infected mice and the ability to present antigen was assessed through ELISPOT to
detect spot forming cells (SFC) secreting IFN-γ. (e) WT BMDC were incubated with T. cruzi or
AdASP-2 in presence or absence of the proteasome inhibitor epoxomicin (EPO) 1 μM and the
expression of MHC and co-stimulatory molecules on CD11c+ cells was assessed by flow cytom-
etry. (f) These BMDC were co-cultured with CD8+ T cells isolated from the spleen of T. cruzi-
infected mice and the ability to present antigen was assessed through ELISPOT to detect spot
forming cells (SFC) secreting IFN-γ.
(TIF)
S2 Fig. Reduced frequencies of CD8+ T cells in TKO animals.WT and TKO mice were
infected s.c. with 104 T. cruzi parasites or left uninfected. Frequencies of (a) CD8+ and (b)
CD4+ T cells in the spleen of these animals are shown. Results are expressed as individual val-
ues and the mean ± SEM for each group. Asterisks indicate that the values observed for TKO
mice were significantly lower than those for WT mice (P<0.05 P<0.001).
(TIF)
S3 Fig. Impaired immunity of CD8+ T cells in TKO animals infected with T. cruzi.WT and
TKOmice were infected s.c. with 104 T. cruzi parasites or left uninfected. Twenty days later, the
response of CD8+ T cells was assessed in the spleen. (a) Frequencies of CD8+ CD44high
CD62Llow cells. (b) Frequencies of specific CD8+ T cells stained with H-2Kb-VNHRFTLV pen-
tamers. (c) Frequencies of CD8+ splenic cells positively stained with anti-TNF and/or anti-
IFN-γ after ex vivo restimulation with the indicated peptides corresponding to known or hypo-
thetical T. cruziMHC class I-restricted epitopes. (d) Numbers of spot forming cells (SFC)
secreting IFN-γ and (e) representative samples from ELISPOT of spleen cells upon restimula-
tion with the indicated peptides. Results are shown as individual values and as the mean ± SEM
for each group. Asterisks indicate that the values observed for TKOmice were significantly
lower than those for WT mice (P<0.05 P<0.01 P<0.001 P<0.0001).
(TIF)
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S4 Fig. Unaltered immunity mediated by CD4+ T cells in TKO animals infected with T.
cruzi.WT and TKOmice were infected s.c. with 104 T. cruzi parasites or left uninfected.
Twenty days later, their spleens were collected and the frequencies of (a) CD4+ CD44high
CD62Llow cells and (b) CD4+ T cells producing IFN-γ and/or TNF were estimated by intracel-
lular staining. The results are expressed as individual values and as the mean ± SEM for each
group.
(TIF)
S5 Fig. Impaired immunity of CD8+ T cells in TKO animals genetically vaccinated against
T. cruzi.WT and TKO mice were primed with empty plasmid DNA (pcDNA3) or a plasmid
vector expressing ASP-2 (pIgCl9) and boosted after 21 days with adenovirus 5 expressing beta-
galactosidase (Adβ-gal) or ASP-2 (AdASP-2), respectively. Fifteen days later, the response of
CD8+ T cells was assessed in the spleen. (a) Frequencies of specific CD8+ T cells stained with
H-2Kb-VNHRFTLV pentamers. (b) Frequencies of CD8+ splenic cells positively stained with
anti-TNF and/or anti-IFN-γ after ex vivo restimulation VNHRFTLV peptide. (c) Numbers of
spot forming cells (SFC) secreting IFN-γ detected by ELISPOT of spleen cells upon restimula-
tion with the peptide VNHRFTLV. Results are shown as individual values and as the
mean ± SEM for each group. Asterisks indicate that the values observed for TKOmice were
significantly lower than those for WT mice (P<0.0001).
(TIF)
S6 Fig. Unaltered response of CD4+ T cells in TKO animals genetically immunized with
Asp-2.WT and TKO mice were immunized with plasmid DNA encoding Asp-2 and boosted
after 21 days with the viral vector AdASP-2. Following immunization, mice were given 2 mg
BrdU i.p. every other day. Fifteen days after boost, their spleens were collected and the frequen-
cies of CD8+ CD44high BrdU+ and CD4+ CD44high BrdU+ cells were determined by flow cytom-
etry. These results are expressed as individual values and as the mean ± SEM for each group
(n = 3). Asterisks indicate that the values observed for TKOmice were significantly lower than
those for WT mice (P<0.05). Alternatively, splenocytes fromWT and TKO immunized mice
were re-stimulated ex vivo with AdASP-2-infected BMDC followed by IFN-γ staining in CD4+
and CD8+ cells.
(TIF)
S7 Fig. Susceptibility of TKO animals to challenge with CL strain of T. cruzi.WT and TKO
mice were challenged intraperitoneally with 100 bloodstream parasites. (a) Parasitemia at dif-
ferent time points after infection. (b) Mortality rates after challenge. The parasitemia values
were compared by one-way ANOVA, which showed that WT mice displayed levels of parasite-
mia that were significantly lower than those of TKO animals (p<0.01 in all cases). Comparison
of the survival curves using the log-rank (Mantel-Cox) test indicated that WT mice survived
significantly longer (p<0.01) than TKO mice did.
(TIF)
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